Impaired Glucagon Responses in Patients with Cystic Fibrosis and Hypoglycemia

“Thus, these data implicate that cystic fibrosis induces defects in glucagon secretion leading to hypoglycemia risk. The association with pancreatic insufficiency suggests a link to pancreatic exocrine disease.” –Andrew Norris

Andrew Norris, MD PhDPost by
Andrew Norris, MD PhD
Director, Pediatric Endocrinology & Diabetes
University of Iowa Stead Family Children’s Hospital

Results from an important recent clinical study of hypoglycemia in patients with cystic fibrosis (CF) are now available. The study was conducted at the University of Washington and headed by preeminent diabetes physiologist Dr. Steven Kahn. Non-diabetic adults with cystic fibrosis were challenged with a 3-hour 75-gram frequently-sampled oral glucose tolerance test.

Half (14/27) of the subjects experienced hypoglycemia during the test. The glycemic pattern during the test was similar between these two groups until 135 minutes and thereafter, when the hypoglycemia group diverged downward. Those who exhibited hypoglycemia were more likely to be pancreatic insufficient. Importantly, those with hypoglycemia had lower plasma insulin & C-peptide levels. Modeling suggest that insulin sensitivity was greater in the subjects with hypoglycemia, accounting for the lower insulin levels. Importantly though, the “oral disposition index” did not differ between the two groups. This indicates that the amount of insulin secreted between the two groups would expected to have the same actions on lowering glucose when accounting for insulin sensitivity. Perhaps one could argue that the “oral disposition index” should have been lower in the hypoglycemia group, but in fact there was a trend towards lower values in this group (P=0.16). Plasma GLP-1 and GIP did not differ between the groups. In the hypoglycemia group, plasma epinephrine rose in the hypoglycemia group, albeit modestly. Cortisol did not rise, though it is not clear how many patients reached the lower blood glucose thresholds needed to trigger cortisol secretion. Growth hormone rose in some but not all patients. Perhaps most importantly, glucagon did not rise with hypoglycemia and did not differ at any point between the two groups.

These results suggest an impairment in counterregulatory response in patients with CF and hypoglycemia. Typically, the threshold for glucagon secretion occurs at less severe degrees of hypoglycemia than for other counterregulatory responses (see this nice review from Elizabeth Seaquist). Furthermore, the hypoglycemia in these subjects was mild. Thus, these data implicate that cystic fibrosis induces defects in glucagon secretion leading to hypoglycemia risk. The association with pancreatic insufficiency suggests a link to pancreatic exocrine disease. However, the mechanisms responsible remain to be determined. The manuscript describing these results is now published in the prestigious journal Diabetologia (link to article).

Senior Endocrine Fellow Publishes Research Discovering Genes that may Modify 22q11.2 Deletion Syndrome.

Dr. Pinnaro

Dr. Pinnaro, pediatric endocrine fellow, has published her recent research that finds several candidate genes which may modify the phenotype of 22q11.2 syndrome. This genetic syndrome can cause congenital structural heart disease, failure of the parathyroid glands to properly form, and immunodeficiency. Although the effects of the syndrome vary from person to person, the reasons for this variability is unknown. Thus, Dr. Pinnaro set out to understand whether other genetic regions might be the reason. Her findings show that various genes might indeed contribute. She is the lead author on the work which is published in the January 2020 issue of Molecular Genetics & Genomic Medicine. Congratulations to Dr. Pinnaro for the results of her hard work in this area.

Might Continuous Glucose Monitoring Discern Diabetes Pathogenesis?

Andrew Norris, MD PhDPost by
Andrew Norris, MD PhD
Director, Pediatric Endocrinology & Diabetes
University of Iowa Stead Family Children’s Hospital

It can be challenging to distinguish type 1 from type 2 diabetes, especially in overweight adolescents and other populations. An upcoming report in the scientific journal Diabetes Care (link here) presents provocative data suggesting that continuous glucose monitoring (CGM) may distinguish forms of diabetes that occur because of loss of insulin secretion capacity (such as type 1) from forms due to insulin resistance (type 2). In particular, when CGM was performed when diabetes was very mild, insulin secretion defects were marked by increased blood glucose variability but normal fasting glucoses, whereas insulin resistance was marked by an overall increase in baseline (i.e. fasting) blood glucose levels.

–Andrew Norris

Endocrine Care of Children with Neuromuscular Disorders

Dr. Curtis

Children, adolescents, and young adults with neuromuscular disorders are at risk for various endocrine complications. For example, Duchenne muscular dystrophy is associated with risk of various endocrine conditions including poor bone health, adrenal insufficiency, obesity, pubertal delay, and short stature. To help with these issues, in 2019, Dr. Vanessa Curtis joined the multidisciplinary Neuromuscular team at the University of Iowa to provide endocrine care to patients in this clinic. This week, Dr. Curtis attended the Parent Project MD meeting in San Diego to further her skills in this emerging area of medicine.

Endocrine Conditions that “Break the Rules”

Andrew Norris, MD PhDPost by
Andrew Norris, MD PhD
Director, Pediatric Endocrinology & Diabetes
University of Iowa Stead Family Children’s Hospital

In pediatrics and medicine we are taught various rules that help us interrogate a person’s health . However, there are a variety of endocrine  disorders that alter normal physiology such that the usual rules no longer apply. Failure to recognize this can lead to erroneous interpretation of a person’s condition, sometimes with even fatal results


“Good urine output indicates that a child is well hydrated”

This is a stalwart rule in pediatrics. When a child is making plenty of urine, this proves that the child is well hydrated. In general this is sage advice, but there are important endocrine exceptions:.

  • Hyperglycemia / diabetes mellitus: When a child’s blood sugar is elevated, this produces an obligate osmotic diuresis. As a result, urine output remains brisk even when the child has become significantly dehydrated. To further exacerbate this, hyperglycemia leads to an osmotic fluid shift from the interstitium to the intravascular compartment, further increasing renal fluid output at the expense of worsening whole body hydration status. For these reasons, the child presenting with severe hyperglycemia is typically more dehydrated than the history and physical examination would suggest. There are cases where clinicians have been falsely reassured by a vomiting child’s brisk urine output, concluding that everything is fine when the child truly has severe hyperglycemia, with sometimes fatal consequences. Pediatricians in training are advised to become practiced and adept at asking children and families about any changes in thirst and urination, as this can be a fairly effective screening tool to assess for out-of-control undiagnosed severe diabetes.
  • Diabetes insipidus: In the child who has diabetes insipidus, urine output is not a reliable indicator of hydration status. When diabetes insipidus is not treated, brisk urine output occurs even in the face of dehydration. When diabetes insipidus is treated with vasopressin or DDAVP, urine output diminishes when the medication is active, even when hydration status is excellent.

“Children and adolescents can tolerate the physical stress of fever or vomiting.”

Typically, children can tolerate common physiological stressors such as significant febrile illness or vomiting / fasting during gastroenteritis. However, often children with underlying medical conditions do not tolerate such physiological stressors as well. Included in such underlying illnesses are several important and relatively common endocrine conditions

  • Adrenal insufficiency: An important component of the response to physiologic stress is increased secretion of adrenal hormones, especially cortisol. Children who are unable to secrete adequate amounts of cortisol can experience hypoglycemia, hyponatremia, and sometimes even cardiovascular collapse in response to physiologic stressors that ordinarily a child could tolerate without difficulty. Conditions in which cortisol secretion in response to stress can be impaired include panhypopituitarism, central adrenal insufficiency, congenital adrenal hyperplasia, Addison’s disease, iatrogenic adrenal suppression, and any form of hypoadrenalism. Children who have impaired mineralocorticoid secretion are at even greater risk for electrolyte imbalance, specifically hyponatremia and hyperkalemia, and cardiovascular collapse. common causes of mineralocorticoid deficiency include congenital adrenal hyperplasia and Addison’s disease. Fortunately stress dose hydrocortisone is an effective means to treat children with these conditions and enable them to better tolerate physiologic stressors.
  • Diabetes mellitus: Pediatric patients with diabetes require special attention to blood glucose and Insulin management during times of physiological stress. During such times, especially in patients with type 1 diabetes, there will be an increased risk of dysglycemia, ketones, dehydration, and diabetic ketoacidosis.
  • Hyperthyroidism: Patients who have active hyperthyroidism can experience significant deterioration during physiological stress and illness. In some cases, illness can precipitate thyroid storm, which can include life-threatening hyperthermia, confusion, diarrhea, tachycardia, arrhythmia, cardiovascular collapse, and coma.

“Children and adolescents tolerate exercise well”

In general children and adolescents can exercise seemingly ad infinitum. however there are a number of medical exceptions to this, including situations in which it is not entirely safe for a child to exercise vigorously. Several endocrine conditions are included among these exceptions to this common rule.

  • Hyperthyroidism: Children and adolescents with active hyperthyroidism typically experience a degree of exercise intolerance. If the hyperthyroidism is significant, some patients will even experience cardiovascular decompensation and/or hyperthermia triggered by vigorous exercise.
  • Ketonemia: children with diabetes can benefit greatly from exercise. however, when diabetes and ketones are present, exercise can exacerbate the degree of ketonemia, and in extreme cases can contribute to the development of diabetic ketoacidosis. standard advice during ketonemia in pediatric patients with diabetes is to administer supplemental insulin, optimize hydration, and delay a vigorous exercise until after the ketones have been cleared.

“Children do not experience electrolyte problems as long as renal function is normal and fluid / electrolyte intake is adequate.”

Although adequate fluid and electrolyte intake coupled with normal renal function is typically sufficient to maintain normal electrolyte balance, there are important exceptions to this rule especially in the endocrine system.

  • Diabetes insipidus: Patients with untreated diabetes insipidus generally develop hypernatremia during normal intakes of fluid and electrolytes. provision of greater than normal amounts of free water and or medical treatment of the diabetes insipidus is required to prevent hypernatremia.
  • SIADH (syndrome of inappropriate ADH secretion): Patients with SIADH have a tendency towards hyponatremia when provided normal amounts of fluid and electrolyte. Fluid restriction is commonly used to prevent hyponatremia in such patients.
  • Mineralocorticoid deficiency: Patients with untreated mineralocorticoid deficiency are prone to hyponatremia and hyperkalemia despite normal fluid and electrolyte intake. Common pediatric causes of mineralocorticoid deficiency include congenital adrenal hyperplasia and Addison’s disease.

“Failure of an infant to gain weight is a feeding issue.”

Many times, when an infant is not adequately gaining weight this can indicate various feeding issues. However, there are many medical diseases which can cause poor weight gain during infancy for reasons other than poor nutritional intake. There are several important to endocrine diseases among these conditions. Congenital adrenal hyperplasia typically causes poor weight gain and failure to thrive beginning towards the end of the first week of life. Neonatal Graves disease, when severe, presents with failure of a newborn to gain weight typically in the first week or two of life. Neonatal diabetes mellitus can present at various times in the first six months of life and can lead to poor weight gain.

Dr. Pesce to Lead National Endocrine Learning Committee

Dr. Pesce

We are pleased to report that Dr. Liuska Pesce, one of our pediatric endocrine faculty, has been selected to co-chair & then chair the Pediatric Endocrinology Self-assessment Program for the Endocrine Society in 2020 & 2021. As part of this group, she helped publish Pediatric ESAP 2019-2020, ESAP Special Edition: Historical Perspectives for Today’s Clinician, and Pediatric ESAP 2017-   2018.

Dr. Larson Ode Publishes on the Endocrine Complications of Cystic Fibrosis.

Dr. Larson Ode

It has been a productive fall for Dr. Larson Ode, who has published 5 review articles focused on various endocrine complications of cystic fibrosis. You can find summaries of these works at the following links: onetwothreefourfive. Dr. Larson Ode is a leading expert in the clinical care and clinical research involving persons with cystic fibrosis who have developed diabetes and other endocrine complications. She sees children and adult patients in the cystic fibrosis clinic to help them manage these conditions. On the research side, she coordinates a variety of clinical studies here at Iowa and also at other academic medical centers across the country to better understand these complications. She is also serving as a career and research mentor to several junior endocrinology faculty across the country to further their expertise and research in this important area. Kudos Dr. Larson Ode on your accomplishments!

Endocrinology & Sports Medicine

Dr. Vanessa Curtis

Sports performance and hormonal systems are closely intertwined. There are several hormonal / endocrine conditions that can greatly impair sports performance. Conversely, exercise can benefit the endocrine system. However, there are times that intense sports participation can adversely affect various hormones. Dr. Vanessa Curtis has interest and expertise in these complex interactions, and treats children and adolescents with such conditions in her clinic. Gender of course has a powerful influence on this interplay. To this end, Dr. Curtis just served as an invited speaker for the 35th Annual University of Iowa Sports Medicine Symposium, speaking on Gender and Sex in Sport. Also along these lines, Dr. Curtis has traveled to various parts of the state of Iowa over the past few years to provide lectures on Athletes with Type 1 Diabetes and Childhood Obesity to residency programs.

Dr. Larson Ode to Help Mentor Faculty Across the Country.

Dr. Larson Ode

There is a strong need to train endocrinologist to help provide expert care for the endocrine complications experienced by patients with cystic fibrosis. For this reason, the Cystic Fibrosis Foundation has established a program to identify national leaders in this area who can help mentor other endocrinologists. We are proud of Dr. Katie Larson Ode, who has been named one of the selected mentors to help train the future leaders in cystic fibrosis endocrinology. This honor includes grant funds to support her time in these efforts.

Dr. Sandberg to Serve as Co-leader for the National Education Subcommittee for the Pediatric Endocrine Society

Dr. Sandberg

Dr. Sandberg is an ardent educator regarding training medical professionals at all levels on how to provide compassionate and informed care for highly vulnerable youth with endocrine needs. To this end, Dr. Sandberg serves as the co-leader of the education subcommittee of one of the related special interest groups at the national Pediatric Endocrine Society. We thank her for her important service in this area and for helping educate health care providers how to provide the best care possible.